Effect of Dietary Components on Gastrointestinal Side Effects Induced by Orlistat, a Lipase Inhibitor

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

June 30, 2012

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

Control

Alli treatment plus placebo (rice flour)

DIETARY_SUPPLEMENT

Capolac

Alli treatment plus Capolac supplement (1200 Ca/d from Capolac)

DIETARY_SUPPLEMENT

Flax fiber

Alli treatment plus flaxseed fibers (5 g/d of dietary fibers from flaxseed)

DIETARY_SUPPLEMENT

Capolac+Flax fiber

Allit treatment plus Capolac (1200 mg Ca/d from Capolac) and Flax fiber (5 g dietary fiber from flaxseed)

Trial Locations (1)

1958

Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen, Frederiksberg C

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Copenhagen

OTHER

NCT01320228 - Effect of Dietary Components on Gastrointestinal Side Effects Induced by Orlistat, a Lipase Inhibitor | Biotech Hunter | Biotech Hunter